IL13RA2 and neoplasm: We have previously reported that histone deacetylase (HDAC) inhibitors dramatically enhanced IL‐13Rα2 expression in receptor‐negative pancreatic cancer cells and in addition, HDAC inhibitors enhanced expression of IL‐13Rα2 in IL‐13Rα2 positive tumours.59